WCLC 2025 - Posters & ePosters-EP.11.21 Efficacy of Immunotherapy in EGFR-Mutant NSCLC After Tyrosine Kinase Inhibitors: Real World Analysis at a Tertiary Oncology Center in Hong Kong

EP.11.21 Efficacy of Immunotherapy in EGFR-Mutant NSCLC After Tyrosine Kinase Inhibitors: Real World Analysis at a Tertiary Oncology Center in Hong Kong

Back to course

Asset Subtitle

Gin Wai Gerry Kwok

Meta Tag

Speaker Gin Wai Gerry Kwok

Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy